Results
|
|
1.
|
Paclitaxel Coated Balloon Fibroplasty: A more effective treatment for chronic symptomatic lead/catheter related central venous obstruction?. MedStar authors:
- Brar, Vijaywant
- Hadadi, Cyrus
- O'Donoghue, Susan
- Towheed, Arooge
- Worley, Seth
- Yacob, Omar
Year: 2021
Citation: - Journal of Cardiovascular Electrophysiology. 32(3):867-870, 2021 03.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department: - Medicine/General Internal Medicine
Medline publication type:
All authors: - Brar V, Hadadi C, O'Donoghue S, Towheed A, Worley S, Yacob O
|
|
|
2.
|
A Patient-Level, Pooled Analysis of Mortality Rates With the Passeo-18 Lux Paclitaxel Drug-Coated Balloon in Peripheral Arterial Disease. MedStar authors:
- Bernardo, Nelson L
- Case, Brian
- Craig, Paige E
- Forrestal, Brian
- Waksman, Ron
- Yerasi, Charan
- Zhang, Cheng
Year: 2021
Citation: - Cardiovascular Revascularization Medicine. 33:49-54, 2021 12.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department: - Interventional Cardiology Fellowship
Medline publication type:
All authors: - Bernardo NL, Case BC, Craig PE, Forrestal BJ, Torguson R, Waksman R, Yerasi C, Zhang C
|
|
|
3.
|
Impact of drug-eluting stents on distal vessels. MedStar authors:
- Desale, Sameer
- Laynez-Carnicero, Ana
- Pakala, Rajbabu
- Pichard, Augusto D
- Romaguera, Rafael
- Sardi, Gabriel L
- Wakabayashi, Kohei
- Waksman, Ron
- Weissman, Neil J
- Xue, Zhenyi
Year: 2012
Citation: - Circulation: Cardiovascular Interventions. 5(2):211-9, 2012 Apr.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Desale S, Ellis SG, Grube E, Laynez-Carnicero A, Mintz GS, Ormiston JA, Pakala R, Pichard AD, Romaguera R, Sardi G, Stone GW, Turco MA, Wakabayashi K, Waksman R, Weissman NJ, Xue Z
|
|
|
4.
|
Risk of mortality with paclitaxel drug-coated balloon in de novo coronary artery disease. [Review] MedStar authors:
- Case, Brian C
- Dan, Kazuhiro
- Forrestal, Brian J
- Garcia-Garcia, Hector M
- Kolm, Paul
- Torguson, Rebecca
- Waksman, Ron
- Weintraub, William S
- Yerasi, Charan
Year: 2020
Citation: - Cardiovascular Revascularization Medicine. 21(4):549-555, 2020 04.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Case BC, Dan K, Forrestal BJ, Garcia-Garcia HM, Kolm P, Torguson R, Waksman R, Weintraub WS, Yerasi C
|
|
|
5.
|
Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study. [] MedStar authors:
Year: 2015
Citation: - Breast Cancer Research & Treatment. 149(1):163-9, 2015 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Bhatt K, Bury MJ, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Goel R, Jacobs SA, Johannes H, Julian TB, Mamounas EP, Provencher L, Rastogi P, Robidoux A, Stella PJ, Swain SM, Tan AR, Thirlwell MP, Wolmark N
|
|
|
6.
|
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2. MedStar authors:
- Swain, Sandra M
- Zapas, John L
Year: 2017
Citation: - Journal of Clinical Oncology. 35(35):3942-3948, 2017 Dec 10
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Atkins JN, Biggs DD, Brufsky AM, Cecchini RS, Fehrenbacher L, Flynn PJ, Ganz PA, Geyer CE Jr, Gross HM, Jeong JH, Mamounas EP, Polikoff J, Rastogi P, Romond EH, Seay TE, Swain SM, Wade JL 3rd, Wahl TA, Wolmark N, Zapas JL
|
